Plexxikon's Series B Round

Plexxikon raised a round of funding on June 24, 2004.

Plexxikon is a drug discovery company that utilizes a structural proteomics approach to discover pharmaceuticals. Using high-throughput X-ray crystallography, the company screens for chemical backbone…

Articles about Plexxikon's Series B Round: